A Japanese company, Yaguchi Electric made Amblyopia treatment equipment and application. The methodology is effective for under 6 years old children. Patients will be free from side effects from existing care method like an eye patching and/or eye drops for deforcusing. The cost of treatment also will be down of course. A leadership of the company would like to contribute solving Amblyopia issue of children in the world with using the equipment. Effectiveness verification has been running in India. An evaluation at some hospitals in Ahmedabad and Mumbai has been done and succeed to make a track record of the treatment. The project team is working to spread the method with other hospitals in India also. Of course, other countries too. Thanks.

1. Gamification of Vision Training
for Amblyopia treatment
Using a Tablet
[SHORT PRESENTATION ONLY]
Dr. Yang Ishigaki, Dr. Tomoya Handa, Dr. Kenji Tanaka

2. Amblyopia (lazy eye)
Amblyopia is a condition that occurs in children in which one eye has
poorer vision than the other.
One of the typical symptoms of Amblyopic eye is Strabismus (squint).

3. of newborn babies are
affected by Amblyopia
for every races.

4. If Treated Before Six Years Old.
Visual Cortex Plasticity
8y4y
Age
2y 6y
Mostly curableMostly curable
Image from quizlet.com

5. Eye PatchingEye Patching
Loss of depth feeling
Rash
Occlusion Amblyopia
Mental Pain
On Healthy Eye
Low Adherence
4 [month] → 30%

6. Fig. Mean compliance with prescribed dose across all individuals still in treatment.
Days with fewer than 10 individuals remaining in treatment not shown.
Visual Psychophysics and Physiological Optics | September 2013 Compliance With Occlusion
Therapy for Childhood Amblyopia Michael P. Wallace; Catherine E. Stewart; Merrick J. Moseley;
David A. Stephens; Alistair R. Fielder
Low Adherence
4 [month] → 30%

7. Powerful eye drops
for defocusing
Powerful eye drops
for defocusing

10. Polarizing Filter
For the Impaired Eye
Light Reduction Filter
For the Good Eye

11. Binocular Gaming Tab;
• The world first binocular treatment device
• Both eyes are always open
• Safer and More Effective
• Easier for patients to use
Binocular Gaming Tab;
• The world first binocular treatment device
• Both eyes are always open
• Safer and More Effective
• Easier for patients to use

12. Eight Games for Vision TrainingEight Games for Vision Training

13. Training Schedule
Clinical Log

14. Eye Patching Occlu-pad®
Vision Training Vision Training

15. E
T. Hand et al. : A Paradigm Shift by ORTe and Occlu-pad, The 121st Annual Meeting of the Japanese
Ophthalmological Society, 2015-04-18 (11:55 - 12:55), Luncheon Seminar Presentation
Treatment by Eye‐Patching
Average = 13.4 Month
3h/day eye‐patching treatment
2012‐2013 Kitasato Univ. Hosp.
N=28 (Anisometropia Amblyopia, Treatment duration > 1y)
Eyesight
LogMAR
Average treatment time
for the full‐correction
= 13.4 month
Treatment Duration [month]

16. T. Hand et al. : A Paradigm Shift by ORTe and Occlu-pad, The 121st Annual Meeting of the Japanese
Ophthalmological Society, 2015-04-18 (11:55 - 12:55), Luncheon Seminar Presentation
Anisometropia amblyopia
Strabismic amblyopia
Treatment by Occlu‐pad®
Eyesight
Treatment Duration [month]
1h/day Occlu‐pad treatment
Average treatment time
for the full‐correction
= 2 month

17. India
830,000
patients/y
Japan
30,000
patients/y
(Shrinking)
USA
118,000
patients/y
China
506,000
patients/y
EU
153,900
patients/y

18. Collaboration with Developing Countries
All India Institute Of Medical Science, AIIMS (Delhi) Sanjeevan Eye Clinic (Mumbai) St. Luke’s Medical Center (Manila)

19. Commoditized
IT/IoT
Devices
Orthotics,
Optometric,
Ophthalmologic
Applications
Vision
Science &
Engineering
Research Interest: fusion of…

20. BACKUP SLIDESBACKUP SLIDES

21. Eye Patch was invented in
10th Century
Mesopotamia

23. Vision
Training
requires…
Vision
Training
requires…
$139 / session
12-24 sessions
(6 months)
$2.5k for 6 months
http://health.costhelper.com/strabismus.html

24. HTS Inc. Amblyotech Inc.
• Enjoyable with no color? No
• Anaglyph for <6y old? Not recom’d
Anaglyph

25. Tangi-Block®Tangi-Block®
Conductive plastic

26. • Japan FDA (Class I Registered)
• US/EU FDA (Not registered yet)
Should qualify as Class I (low risk)
• Japan Patent
• US/EU Patent (preparing)
APPROVALS